Welcome to LookChem.com Sign In | Join Free   Post buying lead  Chemical Tools
Post Buying Lead

Basic information

  • Name:
  • Benzeneacetamide,4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-

  • Superlist Name:
  • Atenolol
  • CAS No.:
  • 29122-68-7

  • Formula:
  • C14H22N2O3
  • Synonyms:
  • Acetamide,2-[p-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]- (8CI);(RS)-Atenolol;Alinor;Altol;Anselol;Antipressan;Apo-Atenolol;AteHexal;Atecard;Atelol;Atenblock;Atendol;Atenet;Ateni;Ateno;Atenolol;Aterol;B-Vasc;Betacard;Tenormin;Tenormine;Tensimin;Tredol;Urosin;Vericordin;Xaten;1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol;Catenol;Catenolol;Corotenol;Farnormin;Hipres;ICI 66082;Internolol;Lo-ten;Lotenal;Normalol;Noten;Oraday;Prenormine;SelesBeta;Serten;Telol;Teno-basan;Tenolin;Tenoprin;
Supplier Location:
China (Mainland)(34)India(26)United States(9)Japan(1)Switzerland(1)Taiwan(1)United Kingdom(1)Germany(1)Hong Kong(1)Brazil(1)Canada(1)More...
Business Type:
Importer/Exporter(45)Other(2)Lab/Research institutions(1)Manufacturers(1)
Certificates:
ISO(3)Production License(0)

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Specification

The IUPAC name of Atenolol is 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide. With the CAS registry number 29122-68-7, it is also named as 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol. The product's categories are Pharmaceutical; Intermediates & Fine Chemicals; Pharmaceuticals; API's; Adrenoceptor. Besides, it is white to off-white crystalline solid, which should be stored in tightly sealed container in a cool, dry place. And you should ensure that the workplaces have good ventilated or exhaust devices. In addition, its molecular formula is C14H22N2O3 and molecular weight is 266.34.

The other characteristics of this product can be summarized as: (1)EINECS: 249-451-7; (2)ACD/LogP: 0.34; (3)# of Rule of 5 Violations: 0; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 1; (8)#H bond acceptors: 5; (9)#H bond donors: 4; (10)#Freely Rotating Bonds: 9; (11)Index of Refraction: 1.54; (12)Molar Refractivity: 74.257 cm3; (13)Molar Volume: 236.659 cm3; (14)Surface Tension: 45.019 dyne/cm; (15)Density: 1.125 g/cm3; (16)Flash Point: 261.059 °C; (17)Melting Point: 154 °C; (18)Enthalpy of Vaporization: 81.95 kJ/mol; (19)Boiling Point: 508.049 °C at 760 mmHg; (20)Solubility: H2O: 0.3 mg/mL; (21)Vapour Pressure: 0 mmHg at 25 °C.

Uses of Atenolol: this chemical is a selective β1 receptor antagonist, which is used primarily in cardiovascular diseases. It is also used for treatment of cardiovascular diseases and conditions such as hypertension, coronary heart disease, arrhythmias, angina (chest pain) and used to treat and reduce the risk of heart complications following myocardial infarction (heart attack). Additionally, it can be used for the treatment of symptoms of Graves Disease. Furthermore, it can be used to produce S(-)-Atenolol.



This reaction needs Rhizopus arrhizus, aq. Phosphate buffer and Butan-1-ol for 6 days. The yield is 75 %.

When you are using this chemical, please be cautious about it as the following: it is irritating to eyes, respiratory system and skin and harmful by inhalation, in contact with skin and if swallowed. In case of contact with eyes, please rinse immediately with plenty of water and seek medical advice. And you should wear suitable protective clothing to avoid contact with skin and eyes. Moreover, please do not breathe dust.

People can use the following data to convert to the molecule structure.
(1)SMILES: CC(C)NCC(COc1ccc(cc1)CC(=O)N)O
(2)InChI: InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
(3)InChIKey: METKIMKYRPQLGS-UHFFFAOYAT
(4)Std. InChI: InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
(5)Std. InChIKey: METKIMKYRPQLGS-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo oral 10204ug/kg (10.204mg/kg) BEHAVIORAL: COMA

CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Anesthesiology. Vol. 83, Pg. 204, 1995.
man TDLo oral 49mg/kg/30D-I (49mg/kg) BEHAVIORAL: EXCITEMENT Journal of Clinical Pyschopharmacology. Vol. 6, Pg. 390, 1986.
man TDLo oral 86mg/kg/60D-I (86mg/kg) BLOOD: "CHANGES IN SERUM COMPOSITION (E.G., TP, BILIRUBIN, CHOLESTEROL)" American Journal of Medicine. Vol. 85, Pg. 586, 1988.
man TDLo oral 129mg/kg/26W- (129mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: COUGH

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Annales de Medecine Interne. Vol. 148, Pg. 505, 1997.
mouse LD50 intraperitoneal 134mg/kg (134mg/kg)   Toksikologicheskii Vestnik. Vol. (4), Pg. 33, 1995.
mouse LD50 intravenous 57mg/kg (57mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980.
mouse LD50 oral 2gm/kg (2000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980.
mouse LD50 subcutaneous > 400mg/kg (400mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980.
rabbit LD50 intravenous 50mg/kg (50mg/kg)   Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 17, Pg. 425, 1979.
rat LD50 intravenous 77mg/kg (77mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980.
rat LD50 oral > 2gm/kg (2000mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980.
rat LD50 subcutaneous > 600mg/kg (600mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 8, Pg. 4579, 1980.
women TDLo oral 16mg/kg (16mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY OBSTRUCTION Annals of Emergency Medicine. Vol. 14, Pg. 161, 1985.
women TDLo oral 42mg/kg/3W-I (42mg/kg)   British Medical Journal. Vol. 294, Pg. 1324, 1987.
women TDLo oral 1080mg/kg/78W (1080mg/kg) BLOOD: LEUKOPENIA

MUSCULOSKELETAL: OTHER CHANGES

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
Journal of Rheumatology. Vol. 13, Pg. 446, 1986.

©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

[Hangzhou]86-571-85317600,85317603,85317620